TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313).

P Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.